[go: up one dir, main page]

UA107581C2 - METHODS FOR REDUCING VIRULICIDAL ACTIVITY OF COMPOSITIONS CONTAINING PCV-2 AND COMPOSITIONS CONTAINING PCV-2 WITH INCREASED IMMUNOGENICITY - Google Patents

METHODS FOR REDUCING VIRULICIDAL ACTIVITY OF COMPOSITIONS CONTAINING PCV-2 AND COMPOSITIONS CONTAINING PCV-2 WITH INCREASED IMMUNOGENICITY

Info

Publication number
UA107581C2
UA107581C2 UAA201203723A UAA201203723A UA107581C2 UA 107581 C2 UA107581 C2 UA 107581C2 UA A201203723 A UAA201203723 A UA A201203723A UA A201203723 A UAA201203723 A UA A201203723A UA 107581 C2 UA107581 C2 UA 107581C2
Authority
UA
Ukraine
Prior art keywords
compositions containing
containing pcv
reducing
methods
pcv
Prior art date
Application number
UAA201203723A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/047654 external-priority patent/WO2011028888A2/en
Publication of UA107581C2 publication Critical patent/UA107581C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Винахід стосується способу зниження віруліцидної активності композиції, що містить антиген PCV-2, а також антигенної та імуногенної композицій, що містять антиген PCV-2, які мають знижену віруліцидну активність.The invention relates to a method of reducing the virucidal activity of compositions containing PCV-2 antigen, as well as antigenic and immunogenic compositions containing PCV-2 antigen, which have reduced virucidal activity.

UAA201203723A 2009-09-02 2010-02-09 METHODS FOR REDUCING VIRULICIDAL ACTIVITY OF COMPOSITIONS CONTAINING PCV-2 AND COMPOSITIONS CONTAINING PCV-2 WITH INCREASED IMMUNOGENICITY UA107581C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23919209P 2009-09-02 2009-09-02
PCT/US2010/047654 WO2011028888A2 (en) 2009-09-02 2010-09-02 Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with an improved immunogenicity

Publications (1)

Publication Number Publication Date
UA107581C2 true UA107581C2 (en) 2015-01-26

Family

ID=52989070

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201203723A UA107581C2 (en) 2009-09-02 2010-02-09 METHODS FOR REDUCING VIRULICIDAL ACTIVITY OF COMPOSITIONS CONTAINING PCV-2 AND COMPOSITIONS CONTAINING PCV-2 WITH INCREASED IMMUNOGENICITY

Country Status (1)

Country Link
UA (1) UA107581C2 (en)

Similar Documents

Publication Publication Date Title
CO6511229A2 (en) METHODS TO REDUCE VIRIED ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH IMPROVED IMMUNOGEICITY
MX352324B (en) Multivalent synthetic nanocarrier vaccines.
EA201591888A1 (en) REPLICATION-DEFECT VACCINES AND VACCINE VECTORS AGAINST FLAVIVIRUSS
EA201300915A1 (en) NEW EUROPEAN PRRSV STRAIN
PH12013502442A1 (en) Inactivated dengue virus vaccine
CO6690760A2 (en) Non-lipidated variants of neisseria meningitidis orf2086 antigens
EA201491811A1 (en) ANTI-LgR5 ANTIBODIES AND IMMUNOCONJUGATES
EA202190619A1 (en) ANTIVIRAL COMPOUNDS
PH12014501835A1 (en) Novel adjuvant compositions
EA201391489A1 (en) COMPOSITIONS WITH REDUCED VISCOSITY
BR112014014118A2 (en) oral care whitening compositions
NI201400022A (en) PHARMACEUTICAL COMPOSITION INCLUDING A CYCLOPOLYSACCHARIDE
CO6751260A2 (en) OMV-based vaccines against burkholderia infections
UY33297A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME
EA201491195A1 (en) METHOD FOR OBTAINING A COMPOSITION CONTAINING GALACT-OLIGOSACCHARIDES
BR112012019844A2 (en) methods and compositions for improving mechanical strength of teeth
BR122021023230B8 (en) Combination vaccine comprising a vaccine comprising a live attenuated parvovirus
EA201500627A1 (en) PREPARATION OF STABLE BEVERAGE
ES2421956A1 (en) Novel crystalline form of sitagliptin sulfate
BR112013019924A8 (en) COMPOSITIONS FOR ORAL CARE
EA201590116A1 (en) METHOD OF OBTAINING SUBSTITUTED TRIAZOLOPIRIDINES
EA201290319A1 (en) APPLICATION OF L3 AND / OR L5 SOURCE AS A VACCINE OR DIAGNOSTIC MEANS FOR PARASITIC DISEASE
CL2012001995A1 (en) Oral composition of an immunogenic agent; method for preparing said composition; method of vaccination or oral reinforcement of an animal against a pathogen
UA107581C2 (en) METHODS FOR REDUCING VIRULICIDAL ACTIVITY OF COMPOSITIONS CONTAINING PCV-2 AND COMPOSITIONS CONTAINING PCV-2 WITH INCREASED IMMUNOGENICITY
MX337070B (en) Vaccine compositions.